A faster pre-submission track, earlier communication for de novo applicants and an “international harmonization” pilot program are among proposed improvements and changes featured in the FDA’s latest draft Medical Device User Fee Amendments (MDUFA) agreement. The agency recently released a draft commitment letter, detailing its proposed agreement with the medtech industry for MDUFA reauthorization. If…
The post FDA releases draft MDUFA VI agreement outlining proposed legislation and program changes appeared first on Medical Design and Outsourcing.